Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

686 ARTÍCULOS , VIENDO DEL 181 AL 195

Group cognitive stimulation therapy versus usual care for people with intellectual disabilities and dementia (CST-IDD) in the UK: protocol for a mixed-methods feasibility randomised controlled trial

Ali A, Aguirre E, Carter J, Hoare S, Brackley K, Goulden N, Hoare Z, Clarke CS, Charlesworth G, Acton D, Spector A.

BMJ Open. 2023 Apr 28;13(4):e072391. doi: 10.1136/bmjopen-2023-072391.

Evaluation of Dementia-Friendly Initiatives, Small-Scale Homelike Residential Care, and Dementia Village Models: A Scoping Review

Krier D, de Boer B, Hiligsmann M, Wittwer J, Amieva H.

J Am Med Dir Assoc. 2023 Jul;24(7):1020-1027.e1. doi: 10.1016/j.jamda.2023.03.024. Epub 2023 Apr 28.

Cardiovascular Risk Management in Persons with Dementia

Nijskens C, Henstra M, Rhodius-Meester H, Yasar S, van Poelgeest E, Peters M, Muller M.

J Alzheimers Dis. 2023;93(3):879-889. doi: 10.3233/JAD-230019.

Dynamic cerebral autoregulation in Alzheimer's disease and mild cognitive impairment: A systematic review

Heutz R, Claassen J, Feiner S, Davies A, Gurung D, Panerai RB, Heus R, Beishon LC.

J Cereb Blood Flow Metab. 2023 Aug;43(8):1223-1236. doi: 10.1177/0271678X231173449. Epub 2023 May 1.

Can Psychopharmacology Do More for Our Patients With Anosognosia?

Rothschild AJ.

J Clin Psychopharmacol. 2023 May-Jun 01;43(3):197-199. doi: 10.1097/JCP.0000000000001687.

Consequence of Dementia and Cognitive Impairment by Primary Nucleation Pathway

Singh A, Ansari VA, Ansari TM, Hasan SM, Ahsan F, Singh K, Wasim R, Maheshwari S, Ahmad A.

Horm Metab Res. 2023 May;55(5):304-314. doi: 10.1055/a-2052-8462. Epub 2023 May 2.

Cytosolic calcium: Judge, jury and executioner of neurodegeneration in Alzheimer's disease and beyond

Webber EK, Fivaz M, Stutzmann GE, Griffioen G.

Alzheimers Dement. 2023 Aug;19(8):3701-3717. doi: 10.1002/alz.13065. Epub 2023 May 3.

[Cerebral amyloid angiopathy-related cognitive decline: small vessels, big problems]

Sveikata L, Stancu P, Sanda N, Carrera E, Assal F.

Rev Med Suisse. 2023 Apr 26;19(824):807-809. doi: 10.53738/REVMED.2023.19.824.807.

[Prevention of dementia]

Riedel-Heller S, Jessen F.

Nervenarzt. 2023 May;94(5):373-374. doi: 10.1007/s00115-023-01474-8. Epub 2023 May 4.

[Motoric cognitive risk syndrome-Setting the course for dementia prevention?]

Theobald P, Herold F, Gronwald T, Müller NG.

Nervenarzt. 2023 Oct;94(10):944-950. doi: 10.1007/s00115-023-01487-3. Epub 2023 May 4.

Do hearing loss interventions prevent dementia?

Dawes P, Völter C.

Z Gerontol Geriatr. 2023 Jul;56(4):261-268. doi: 10.1007/s00391-023-02178-z. Epub 2023 May 4.

Effect of Multicomponent Exercise on Cognition, Physical Function and Activities of Daily Life in Older Adults With Dementia or Mild Cognitive Impairment: A Systematic Review and Meta-analysis

Yan J, Li X, Guo X, Lin Y, Wang S, Cao Y, Lin H, Dai Y, Ding Y, Liu W.

Arch Phys Med Rehabil. 2023 Dec;104(12):2092-2108. doi: 10.1016/j.apmr.2023.04.011. Epub 2023 May 2.

The heterogeneity of late-life depression and its pathobiology: a brain network dysfunction disorder

Jellinger KA.

J Neural Transm (Vienna). 2023 Aug;130(8):1057-1076. doi: 10.1007/s00702-023-02648-z. Epub 2023 May 5.

The association between cataract and incidence of cognitive impairment in older adults: A systematic review and meta-analysis

Xiong Z, Li X, Yang D, Xiong C, Xu Q, Zhou Q.

Behav Brain Res. 2023 Jul 26;450:114455. doi: 10.1016/j.bbr.2023.114455. Epub 2023 May 4.

[Influencing factors of mild cognitive impairment among the Chinese elderly: a meta-analysis]

Zhang YF, Zhang HX, Yang JC, Qu YM, Jiang Y, Li JL.

Zhonghua Yi Xue Za Zhi. 2023 May 9;103(17):1340-1348. doi: 10.3760/cma.j.cn112137-20220819-01765.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias